The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Silexion Therapeutics Corp’s current trading price is -98.51% away from its 52-week high, while its distance from the 52-week low is 1.11%. The stock’s price range for this period has been between $1.80 and $122.02 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 6.84 million for the day, a number notably higher than the average daily volume of 0.8 million over the last three months.
Silexion Therapeutics Corp experienced a somewhat shaky performance in the stock market.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Silexion Therapeutics Corp (SLXN) has experienced a quarterly decline of -35.41% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.92M.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 4.8179, with a change in price of -18.5100. Similarly, Silexion Therapeutics Corp recorded 721,884 in trading volume during the last 100 days, posting a change of -91.00%.
SLXN Stock Stochastic Average
Silexion Therapeutics Corp’s raw stochastic average for the past 50 days is presently 3.23%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 3.23%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 3.26% and 2.93%, respectively.
SLXN Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -9.45% this year. Over the last six months, there has been a stronger performance of -98.23%. The price of SLXN leaped by -33.09% during the last 30 days period. For the last 5-days stocks have slided -15.35%.
